Cited by 58Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsCancer-related Molecular Pathways

Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms

Open access
Davis, Terence, Singhrao, Sim K., Wyllie, Fiona S., Haughton, Michele F., Smith, Paul J., Wiltshire, Marie, Wynford-Thomas, David, Jones, Christopher J. +2 more·2003·Journal of Cell Science

Abstract

Werner-syndrome fibroblasts have a reduced in vitro life span before entering replicative senescence. Although this has been thought to be causal in the accelerated ageing of this disease, controversy remains as to whether Werner syndrome is showing the acceleration of a normal cellular ageing mechanism or the occurrence of a novel Werner-syndrome-specific process. Here,we analyse the signalling pathways responsible for senescence in Werner-syndrome fibroblasts. Cultured Werner-syndrome (AG05229) fibroblasts senesced after ∼20 population doublings with most of the cells having a 2N content of DNA. This was associated with hypophosphorylated pRb and high levels of p16Ink4a and p21Waf1. Senescent AG05229 cells re-entered the cell cycle following microinjection of a p53-neutralizing antibody. Similarly, production of the human papilloma virus 16 E6 oncoprotein in presenescent AG05229 cells resulted in senescence being bypassed and extended cellular life span. Werner-syndrome fibroblasts expressing E6 did not proliferate indefinitely but reached a second proliferative lifespan barrier, termed Mint, that could be bypassed by forced production of telomerase in post-M1 E6-producing cells. The conclusions from these studies are that: (1) replicative senescence in Werner-syndrome fibroblasts is a telomere-induced p53-dependent event; and(2) the intermediate lifespan barrier Mint is also a telomere-induced event, although it appears to be independent of p53. Werner-syndrome fibroblasts resemble normal human fibroblasts for both these proliferative lifespan barriers, with the strong similarity between the signalling pathway linking telomeres to cell-cycle arrest in Werner-syndrome and normal fibroblasts providing further support for the defect in Werner syndrome causing the acceleration of a normal ageing mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/jcs.00331

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Premature senescence of human WS fibroblasts is p53 dependent.

    “the premature senescence of human WS fibroblasts is p53 dependent (Davis et al., 2003”

    From DNA Repair, Genome Stability, and Aging (2005) · cites this paper as Davis et al., 2003

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Epstein, C. J., Martin, G. M., Schultz, A. L. and Motulsky, A. G. (1996). Werner syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 45, 177-221.

Cited by

Sorted by citations

Authors
Davis, T., Singhrao, S. K., Wyllie, F. S., Haughton, M. F., Smith, P. J., Wiltshire, M., Wynford-Thomas, D., Jones, C. J., Faragher, R. G. A., & Kipling, D.
Affiliations
  • Cardiff University (GB)
  • Department of Pathology, University of Wales College of Medicine, Heath Park,Cardiff, CF14 4XN, UK
  • University of Brighton (GB)
Corresponding author
Kipling, David
Venue
Journal of Cell Science
Published
2003-04-01
Volume
116
Issue
7
Pages
1349-1357
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2040448220
Cited by
58
References
49
Citations by year
2021: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 4 · 2012: 5
FWCI
4.23
Type
journal article
Language
en
Open access
Locations
  • Journal of Cell Science (publishedVersion)
  • PubMed (publishedVersion)
  • University of Brighton Repository (University of Brighton) (publishedVersion, cc-by)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • University of Brighton Repository (University of Brighton) (submittedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Biotechnology and Biological Sciences Research Council
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Werner syndrome, replicative senescence, telomeres, p53, p53-independent senescence, p16INK4a, p21, pRb hypophosphorylation, HPV16 E6, telomerase, cellular lifespan, accelerated aging, cell cycle arrest, fibroblasts
MeSH terms
Aging, Antibodies, Cell Division, Cell Line, DNA, DNA-Binding Proteins, Fibroblasts, Humans, Longevity, Mitosis, Oncogene Proteins, Viral, Ploidies, Werner Syndrome, Signal Transduction, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cyclins, Telomere, Cellular Senescence, Genes, cdc, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Cyclin-Dependent Kinase Inhibitor p21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review